Compare DexCom, Inc. (DXCM) vs General Mills, Inc. (GIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs General Mills, Inc. — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while General Mills, Inc. trades at $32.33 (market cap $17.43B). The key difference: DexCom, Inc. is the larger of the two by market cap, and General Mills, Inc. pays a 7.49% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and General Mills, Inc. for 106 Days on average.
| DXCM | GIS | |
|---|---|---|
Market Cap | $31.86B | $17.43B |
Volume | 3,607,070 | 16,554,362 |
Sector | Health | Consumer Staples |
52-Week High | $92.34 | $49.36 |
52-Week Low | $54.84 | $31.67 |
Typical Hold Time | 62 Days | 106 Days |
Enterprise Value | $31.32B | $30.61B |
Dividend Yield | — | 7.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
General Mills (GIS) trades at $32.29, up 1.64% today, showing mixed signals with bearish technical indicators but attractive valuation metrics including a P/E of 9.23 and P/S of 0.96. Recent Q2 2026 earnings beat expectations at $0.95 EPS versus $0.797 expected, though Q4 2025 missed. The company maintains dividend payments of $0.61 per share while facing profitability challenges with negative net income margin and ROE. Leadership transition is underway with Dana McNabb set to succeed Jeff Harmening as CEO.
Outlook remains cautious with analyst consensus at Hold (61%) and $36 price target. Key risks include declining revenue trends, margin pressure, and high debt levels at 45% of assets. The stock offers value appeal but requires successful execution of the $3B savings plan and turnaround strategy to drive sustainable growth amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →
